Inhibition	O
by	O
N	O
-	O
(	O
phosphonacetyl	O
)	O
-	O
L	O
-	O
aspartate	O
of	O
Ehrlich	B-Cancer
ascites	I-Cancer
tumour	I-Cancer
growth	O
and	O
glucose	O
transport	O
.	O

N	O
-	O
(	O
Phosphonacetyl	O
)	O
-	O
L	O
-	O
aspartate	O
(	O
PALA	O
)	O
suppressed	O
the	O
growth	O
of	O
Ehrlich	B-Cell
ascites	I-Cell
tumour	I-Cell
cells	I-Cell
in	O
vivo	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
.	O

Simultaneously	O
as	O
the	O
growth	O
rate	O
decreased	O
,	O
the	O
cellular	B-Cell
uptake	O
of	O
glucose	O
and	O
the	O
density	O
of	O
a	O
class	O
of	O
glucose	O
-	O
reversible	O
binding	O
sites	O
for	O
cytochalasin	O
B	O
on	O
the	O
cell	B-Cellular_component
surface	I-Cellular_component
were	O
also	O
found	O
to	O
be	O
reduced	O
.	O

There	O
is	O
a	O
highly	O
significant	O
correlation	O
between	O
the	O
magnitude	O
of	O
changes	O
in	O
the	O
number	O
of	O
cytochalasin	O
B	O
binding	O
sites	O
and	O
the	O
magnitude	O
of	O
changes	O
in	O
glucose	O
uptake	O
.	O

The	O
physiological	O
significance	O
of	O
these	O
observations	O
are	O
discussed	O
.	O

